Beroni : Issues US$500K of Convertible Notes

Beroni Group Issues US$500K of Convertible Notes

NEW YORK and SYDNEY, Australia, January 31, 2022 - Beroni Group (OTCQX: BNIGF; NSX: BTG) ("Beroni" or the "Company"), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, today announced that it has raised US$500K from the issue of convertible notes to an investor in China with the following key terms:

• Number of Convertible Notes - 5,000
• Face value of each Convertible Note - US$100
• Maturity Date - January 28, 2023
• Interest Rate - Nil
• Some or all of the Convertible Notes can be converted at the election of the Convertible Noteholder at any time prior to maturity.
• The Number of Shares to be issued to the Convertible Noteholder in respect of each Convertible Note will be calculated by dividing the Face Value of the Notes by the Conversion Price of US$7.
• If, upon the listing of the Company on NASDAQ or NYSE, the Issue Price is lower than the Conversion Price, additional convertible notes will be issued to the Convertible Noteholder that would have been issued if the Convertible Notes were issued at the Issue Price instead of the Conversion Price.
• On the Maturity Date, all Convertible Notes held by the Convertible Noteholder that have not otherwise been converted will be automatically converted.

Funds raised from the Convertible Notes will be used for general working capital of the Company.

-###-

About Beroni Group Limited

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approvedvirus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. It is listed on the National Stock Exchange of Australia and traded on the OTC markets in the USA. To learn more about Beroni, please visit www.beronigroup.com.

Forward-Looking Statements Disclaimer

This press release contains forward-looking statements or forward-looking information, within the meaning of applicable United States and Australian securities laws with respect to the Company. By their nature, forward-looking statements are subject to a variety of factors that could cause actual results to differ materially from the results suggested by the forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements. Generally forward-looking statements can be identified by the use of terminology such as "anticipate", "will", "expect", "may", "continue", "could", "estimate", "forecast", "plan", "intend", "believe", "potential" and similar expressions.

Forward-looking information contained in this press release is based on Company management's opinions, estimates and assumptions in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Forward-looking statements involve significant risks, uncertainties and assumptions, and there can be no assurance that such statements, or its underlying risks, uncertainties and assumptions will prove to be accurate. Factors that could cause actual results or events to differ materially include, without limitation, risks related to laws, rules and regulation applicable to the Company as well as the industry in which it operates (including in respect of taxes and other levies), economic or market conditions on both a national and global level, currency fluctuations, risks inherent to other entities at a similar stage of development and industry in which the Company currently is, competition from the Company's competitors, unsatisfactory development or marketing of the Company and/or its products or services, regulatory action or litigation (including product liability claims), and failure to enter into agreements or arrangements with other parties on fair or reasonable terms. Forward-looking information is made only as of the date on which it is provided and, except as may be required by applicable laws, the Company disclaims any intent or obligation to update such forward-looking information whether as a result of new information, future events or otherwise.

For more information, please contact us at:

Tel: [phone]

Email: [e-mail]

Website: www.beronigroup.com